Form 4/A for CSL CARLISLE COMPANIES INC
Accepted 2025-02-11 00:00:00 ET · period of report 2025-01-28 · accession 0000790051-25-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2025-02-11 | 2025-01-28 | CSL | Wallace Susan | VP, CHRO | A - Grant | $0.00 | +280 | 1,218 | +30% | $0 |
| DA | 2025-02-11 | 2025-01-28 | CSL | Wallace Susan | VP, CHRO | A - Grant | $0.00 | +985 | 985 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-28 | A | A | 280 | $0.00 | 1,218 | D | — | — | (F1) Represents a grant of 280 restricted shares from the issuer as an executive officer of the issuer. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2025-01-28 | A | A | 985 | $0.00 | 985 | D | $395.46 · — to 2035-01-27 | 985 Common Stock | (F2) The option vests in three equal annual installments beginning on January 28, 2026. |